A simple method for quantitative measurement of C3d in human plasma

Area of Science:

• Immunochemistry
• Clinical Chemistry

Background:

• Complement component 3 (C3) plays a crucial role in the immune system.
• C3 activation leads to the formation of various fragments, including C3d, which are important biomarkers.

Purpose of the Study:

• To develop and validate a simple, reliable method for quantifying C3d in human plasma.
• To establish reference levels of circulating C3d in healthy individuals.

Main Methods:

• Utilized rocket affinoimmunoelectrophoresis incorporating Concanavalin A (Con-A) Sepharose.
• The method leverages the differential binding of C3, C3c, and C3d to Con-A for separation and quantification.
• Quantification performed on small plasma volumes (2-20 µL) without prior sample manipulation.

Main Results:

• Demonstrated that native C3 and C3c bind to Con-A, while C3d does not.
• Successfully quantified free C3d in EDTA-plasma samples.
• Found that circulating C3d levels in healthy donors are typically below 3% of maximally convertible C3d.

Conclusions:

• A novel and efficient method for C3d quantification in human plasma has been established.
• The assay is suitable for routine clinical use due to its simplicity and minimal sample requirement.
• Baseline levels of C3d in healthy individuals are generally low, providing a reference for disease state analysis.